Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ethos Technologies Inc. - Class A Common Stock (NQ:LIFE)

10.69 +0.44 (+4.24%)
Streaming Delayed Price Updated: 11:55 AM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ethos Technologies Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >
News headline image
2 Small-Cap Biotech Stocks Well Positioned for a Breakout ↗
Clinical trial results expected in the weeks ahead could push shares of these small-cap drugmakers through the roof. 
Via The Motley Fool
News headline image
3 Innovation Stocks With Parabolic Upside Potential ↗
These three growth stocks might be deeply undervalued. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
1 Small-Cap Biotech Stock Poised for a Breakout ↗
This developmental biotech is nearing a key inflection point. 
Via The Motley Fool
Topics Economy
News headline image
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025 ↗
These 10X penny stocks have the potential to mint millionaires with enough capital but buy wisely as the risk is real. 
Via InvestorPlace
News headline image
LIFE Stock Earnings: aTyr Pharma Beats EPS, Beats Revenue for Q1 2024 ↗
LIFE stock results show that aTyr Pharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Recap: aTyr Pharma Q4 Earnings ↗
 
Via Benzinga
News headline image
aTyr Pharma's Earnings Outlook ↗
 
Via Benzinga
News headline image
Analyst Expectations for aTyr Pharma's Future ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
3 Penny Stocks That Could Be Multibaggers in the Making: March Edition ↗
Penny stocks are incredibly risky. However, if you can handle the heat, these ideas might be worth your while. 
Via InvestorPlace
News headline image
LIFE Stock Earnings: aTyr Pharma Misses EPS for Q4 2023 ↗
LIFE stock results show that aTyr Pharma missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
The 3 Best Penny Stocks to Buy in February 2024 ↗
With proposed FED rate cuts incoming, these are the penny stocks that are likely to see a spark into new rallies. 
Via InvestorPlace
News headline image
$12M Bet On This Trucking Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗
The Dow Jones closed higher on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks... 
Via Benzinga
News headline image
The Latest Analyst Ratings for aTyr Pharma ↗
 
Via Benzinga
News headline image
aTyr Pharma: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Where aTyr Pharma Stands With Analysts ↗
 
Via Benzinga
News headline image
aTyr Pharma's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 14, 2024 ↗
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
News headline image
aTyr Pharma's Cash Runway Secured till 2026, Despite Lack of Material Catalysts: Oppenheimer Analyst ↗
Oppenheimer has downgraded aTyr Pharma Inc (NASDAQ: LIFE) to Perform from Outperform, citing a few material catalysts in the next few quarters. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2023 ↗
 
Via Benzinga
News headline image
7 Growth Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2023 ↗
Bard AI has consistently outperformed, and it has identified seven growth stocks that it believes will deliver triple-digit returns. 
Via InvestorPlace
News headline image
3 Stocks and Cryptos With the Highest Potential Returns ↗
If you're only worried about upside, these stocks and cryptos have some of the highest possible returns in the market. 
Via InvestorPlace
News headline image
7 Hot Growth Stocks Poised to Triple in 2023 ↗
These hot growth stocks to buy can triple in price in 2023, with some holding impressive upside that's much higher. 
Via InvestorPlace
News headline image
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank ↗
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
This Company Is Beginning A Pivotal Phase 3 EFZO-FIT™ Study. Could It Be A Much-Needed Treatment For Pulmonary Sarcoidosis? ↗
Most people may never have heard of sarcoidosis, an inflammatory disease that affects about 1.2 million people worldwide.  
Via Benzinga
News headline image
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 64 companies achieved new lows for the year. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.